527 related articles for article (PubMed ID: 15047993)
41. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
[TBL] [Abstract][Full Text] [Related]
42. Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
Sendagire H; Kyabayinze D; Swedberg G; Kironde F
Trop Med Int Health; 2005 Jun; 10(6):537-43. PubMed ID: 15941416
[TBL] [Abstract][Full Text] [Related]
43. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
[TBL] [Abstract][Full Text] [Related]
45. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C; Musset L; Legrand E; Tichit M; Briolant S; Fusai T; Rogier C; Bouchier C; Picot S; Ménard D
Am J Trop Med Hyg; 2009 Jul; 81(1):19-22. PubMed ID: 19556560
[TBL] [Abstract][Full Text] [Related]
46. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
Malamba SS; Mermin J; Reingold A; Lule JR; Downing R; Ransom R; Kigozi A; Hunt BM; Hubbard A; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
[TBL] [Abstract][Full Text] [Related]
47. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
Nzila AM; Mberu EK; Sulo J; Dayo H; Winstanley PA; Sibley CH; Watkins WM
Antimicrob Agents Chemother; 2000 Apr; 44(4):991-6. PubMed ID: 10722502
[TBL] [Abstract][Full Text] [Related]
48. Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran?
Eskandarian AA; Keshavarz H; Basco LK; Mahboudi F
Trans R Soc Trop Med Hyg; 2002; 96(1):96-8. PubMed ID: 11926005
[TBL] [Abstract][Full Text] [Related]
49. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
[TBL] [Abstract][Full Text] [Related]
50. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698
[TBL] [Abstract][Full Text] [Related]
51. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
[TBL] [Abstract][Full Text] [Related]
52. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Infect Genet Evol; 2012 Jan; 12(1):38-44. PubMed ID: 22020253
[TBL] [Abstract][Full Text] [Related]
53. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
[TBL] [Abstract][Full Text] [Related]
54. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
[TBL] [Abstract][Full Text] [Related]
55. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
Malar J; 2007 May; 6():54. PubMed ID: 17477865
[TBL] [Abstract][Full Text] [Related]
57. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Wang P; Read M; Sims PF; Hyde JE
Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania.
Jelinek T; Rønn AM; Lemnge MM; Curtis J; Mhina J; Duraisingh MT; Bygbjerg IC; Warhurst DC
Trop Med Int Health; 1998 Aug; 3(8):605-9. PubMed ID: 9735930
[TBL] [Abstract][Full Text] [Related]
59. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
[TBL] [Abstract][Full Text] [Related]
60. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
